mRNA |
Nilotinib |
FIMM |
pan-cancer |
AAC |
0.22 |
0.2 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.2 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |